Inspire Medical Systems is a medical devices business based in the US. Inspire Medical Systems shares (INSP) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $198.93 – a decrease of 3.87% over the previous week. Inspire Medical Systems employs 1,011 staff and has a trailing 12-month revenue of around $705.7 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $198.93 |
|---|---|
| 52-week range | $123.00 - $257.40 |
| 50-day moving average | $198.74 |
| 200-day moving average | $187.44 |
| Wall St. target price | $232.19 |
| PE ratio | 947.2857 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.21 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $198.93 from 2024-10-15
| 1 week (2024-10-09) | -3.87% |
|---|---|
| 1 month (2024-09-16) | -4.33% |
| 3 months (2024-07-16) | 36.42% |
| 6 months (2024-04-16) | -10.24% |
| 1 year (2023-10-16) | 31.77% |
|---|---|
| 2 years (2022-10-14) | 21.28% |
| 3 years (2021-10-15) | 245.18 |
| 5 years (2019-10-16) | 265.88% |
Valuing Inspire Medical Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inspire Medical Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Inspire Medical Systems's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 947x. In other words, Inspire Medical Systems shares trade at around 947x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
| Revenue TTM | $705.7 million |
|---|---|
| Operating margin TTM | 2.6% |
| Gross profit TTM | $341.7 million |
| Return on assets TTM | -1.33% |
| Return on equity TTM | 1.03% |
| Profit margin | 0.85% |
| Book value | $21.41 |
| Market Capitalization | $5.9 billion |
TTM: trailing 12 months
We're not expecting Inspire Medical Systems to pay a dividend over the next 12 months.
Over the last 12 months, Inspire Medical Systems's shares have ranged in value from as little as $123 up to $257.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Inspire Medical Systems's is 1.344. This would suggest that Inspire Medical Systems's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Inspire Medical Systems, Inc. , a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. .
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
Steps to owning and managing SEEL, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing MRNA, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.